These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 2969399)

  • 1. Ligand-loaded but not free complement receptors for C3b/C4b and C3d co-cap with cross-linked B cell surface IgM and IgD.
    Tsokos GC; Thyphronitis G; Jack RM; Finkelman FD
    J Immunol; 1988 Aug; 141(4):1261-6. PubMed ID: 2969399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between murine B lymphocyte surface membrane molecules. Loaded but not free receptors for complement and the Fc portion of IgG co-cap independently with cross-linked surface Ig.
    Tsokos GC; Kinoshita T; Thyphronitis G; Patel AD; Dickler HB; Finkelman FD
    J Immunol; 1990 Jan; 144(1):239-43. PubMed ID: 2136881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between lymphocyte membrane molecules. II. Characterization of an interaction between B lymphocyte surface IgD and Fc IgG receptors that differs from the surface IgM-Fc IgG receptor interaction.
    Dickler HB; Kubicek MT; Finkelman FD
    J Immunol; 1982 Mar; 128(3):1271-7. PubMed ID: 6799572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of the stimulation of complement receptors CR1 (CD35) and CR2 (CD21) on cell proliferation and intracellular Ca2+ mobilization of chronic lymphocytic leukemia B cells.
    Hivroz C; Fischer E; Kazatchkine MD; Grillot-Courvalin C
    J Immunol; 1991 Mar; 146(6):1766-72. PubMed ID: 1826011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A spatial association between membrane IgD and the receptor for C3b (CR1) at the cell surface of murine B lymphocytes.
    Sitia R; Rabellino EM; Sockell M; Hämmerling U
    J Immunol; 1981 Jan; 126(1):107-12. PubMed ID: 7005331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties.
    Goroff DK; Stall A; Mond JJ; Finkelman FD
    J Immunol; 1986 Apr; 136(7):2382-92. PubMed ID: 2419432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered surface distribution of both C3b receptors and Fc receptors on neutrophils induced by anti-C3b receptor or aggregated IgG.
    Jack RM; Fearon DT
    J Immunol; 1984 Jun; 132(6):3028-33. PubMed ID: 6233366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis.
    Kozono Y; Duke RC; Schleicher MS; Holers VM
    Eur J Immunol; 1995 Apr; 25(4):1013-7. PubMed ID: 7737272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-induced Ca2+ signaling and desensitization in B cells.
    Lazarus AH; Mills GB; Delovitch TL
    J Immunol; 1990 Jun; 144(11):4147-55. PubMed ID: 2341715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
    Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
    J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface immunoglobulin phenotype of complement receptor-positive and complement receptor-negative B cells of normal and xid immunodeficient mice.
    Lindsten T; Finkelman FD; Thompson CB; Andersson B; Scher I
    Eur J Immunol; 1984 Apr; 14(4):329-35. PubMed ID: 6609823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of B cells in vivo by a Fab/Fc fragment of a monoclonal anti-IgD antibody requires an interaction between the antibody fragment and a cellular IgG Fc receptor.
    Goroff DK; Finkelman FD
    J Immunol; 1988 May; 140(9):2919-24. PubMed ID: 2966202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin.
    Mond JJ; Seghal E; Kung J; Finkelman FD
    J Immunol; 1981 Sep; 127(3):881-8. PubMed ID: 6790620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential interaction of the C3b/C4b receptor and MHC class I with the cytoskeleton of human neutrophils.
    Jack RM; Ezzell RM; Hartwig J; Fearon DT
    J Immunol; 1986 Dec; 137(12):3996-4003. PubMed ID: 2946771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes.
    Carter RH; Spycher MO; Ng YC; Hoffman R; Fearon DT
    J Immunol; 1988 Jul; 141(2):457-63. PubMed ID: 2968402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis.
    Phillips NE; Parker DC
    J Immunol; 1984 Feb; 132(2):627-32. PubMed ID: 6228594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement receptor lymphocytes in the rabbit I. an SIg-negative subpopulation in the appendix.
    Green WR; Fanger MW
    J Immunol; 1976 Nov; 117(5 Pt.2):1805-11. PubMed ID: 993581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of neonatal anti-delta antibody treatment on the murine immune system. I. Suppression of development of surface IgD+ B cells and expansion of a surface IgM+ IgD- B lymphocyte population.
    Finkelman FD; Mond JJ; Metcalf ES
    J Immunol; 1983 Aug; 131(2):593-600. PubMed ID: 6602840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones.
    Arvieux J; Yssel H; Colomb MG
    Immunology; 1988 Oct; 65(2):229-35. PubMed ID: 2973431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.